Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Tesla renames FSD to Tesla Assisted Driving in Europe

Tesla renames FSD to Tesla Assisted Driving in Europe

智通财经智通财经2026/10/09 13:11
Show original

Tesla (TSLA.US) is downplaying the name "Full Self-Driving" in an effort to gain approval for its driver assistance system in Europe and to distance itself from the long-criticized, potentially misleading term. In recent days, Tesla has started using the name "Tesla Assisted Driving" on its European websites. Meanwhile, its U.S. website still refers to the technology as "Full Self-Driving (Supervised)."

Tesla (TSLA.US) is downplaying the term "Full Self-Driving" to gain approval for its driver-assistance system in Europe and to distance itself from this long-criticized and potentially misleading name. In recent days, Tesla has started using the term "Tesla Assisted Driving" on its European websites. Meanwhile, its US website still refers to the technology as "Full Self-Driving (Supervised)".
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%